Managing pain in patients with aberrant drug-taking behaviors

Journal of Supportive Oncology

Volumn 3, Issue 1, 2005, Pages 83-86

  Passik, Steven D ^a   Kirsh, Kenneth L ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE; NARCOTIC ANALGESIC AGENT;

ANALGESIA; ARTICLE; CANCER PAIN; COMPULSION; CRIMINAL BEHAVIOR; DAILY LIFE ACTIVITY; DRUG DEPENDENCE; DRUG TOLERANCE; DRUG UTILIZATION; EMPATHY; HUMAN; INDIVIDUALIZATION; INFORMATION PROCESSING; INTERPERSONAL COMMUNICATION; MEDICAL ASSESSMENT; OPIATE ADDICTION; PATIENT CARE; PHYSICIAN ATTITUDE; PRESCRIPTION; PREVALENCE; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RISK BENEFIT ANALYSIS; SOCIAL PSYCHOLOGY; SOCIAL SUPPORT; SUBSTANCE ABUSE; TOXICITY TESTING; UNITED STATES; ADDICTION; COMPARATIVE STUDY; FEMALE; HOSPITALIZATION; INTRACTABLE PAIN; MALE; NEOPLASM; PAIN ASSESSMENT; PAIN THRESHOLD; PATHOPHYSIOLOGY; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; TREATMENT OUTCOME;

ANALGESICS, OPIOID; BEHAVIOR, ADDICTIVE; FEMALE; HUMANS; MALE; NEOPLASMS; PAIN MEASUREMENT; PAIN THRESHOLD; PAIN, INTRACTABLE; QUALITY OF LIFE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 15544370294     PISSN: 15446794     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Colliver JD, Kopstein AN. Trends in cocaine abuse reflected in emergency room episodes reported to DAWN. Public Health Rep 1991;106:59-68.
2. Groerer J, Brodsky M. The incidence of illicit drug use in the United States, 1962-1989. Br J Addict 1992;87:1345-1351.
3. Regier DA, Meyers JK, Dramer M, et al. The NIMH Epidemiologic Catchment Area program. Arch Gen Psychiatry 1984;41:934-941.
4. Burton RW, Lyons JS, Devens M, Larson DB. Psychiatric consultation for psychoactive substance disorders in the general hospital. Gen Hosp Psychiatry 1991;13:83-87.
5. Derogatis LR, Morrow GR, Fetting J, et al. The prevalence of psychiatric disorders among cancer patients. JAMA 1983;249:751-757.
6. Twycross RG. Clinical experience with diamorphine in advanced malignant disease. Int J Clin Pharmacol 1974;7:184-198.
7. Kanner RM, Foley KM. Patterns of narcotic drug use in a cancer pain clinic. Ann NY Acad Sci 1981;362:161-172.
8. Chapman CR, Hill HF. Prolonged morphine self-administration and addiction liability:evaluation of two theories in a bone marrow transplant unit. Cancer 1989;63:1636-1644.
9. France RD, Urban BJ, Keefe FJ. Long-term use of narcotic analgesics in chronic pain. Soc Sci Med 1984;19:1379-1382.
10. Portenoy RK, Foley KM. Chronic use of opioid analgesics in non-malignant pain: report of 38 cases. Pain 1986;25:171-186.
11. Urban BJ, France RD, Steinberger DL, Scott DL, Maltbie AA. Long-term use of narcotic/antidepressant medication in the management of phantom limb pain. Pain 1986;24:191-196.
12. Foley KM. Clinical tolerance to opioids. In: Basbaum AI, Besson J-M, eds. Towards a New Pharmacotherapy of Pain. Chichester, UK:John Wiley & Sons; 1991:181.
13. Zenz M, Strumpf M, Tryba M. Long-term opioid therapy in patients with chronic nonmalignant pain. J Pain Symptom Manage 1992;7:69-77.
14. Portenoy RK. Opioid tolerance and efficacy: basic research and clinical observations. In: Gebhardt G, Hammond D, Jensen T, eds. Proceedings of the VII World Congress on Pain. Progress in Pain Research and Management. Vol. 2. Seattle, Wash: IASP Press; 1994:595.
15. Rinaldi RC, Steindler EM, Wilford BB, Goodwin D. Clarification and standardization of substance abuse terminology. JAMA 1988;259:555-557.
16. Passik SD, Weinreb HJ. Managing chronic non-malignant pain: overcoming obstacles to the use of opioids. Adv Ther 2000;17:70-83.
17. Lundberg JC, Passik SD. Alcohol and cancer: a review for psycho-oncologists. Psychooncology 1997;6:253-266.
18. Passik SD, Portenoy RK. Substance abuse issues in palliative care. In: Berger A, Portenoy RK, Weissman DE, eds. Principles and Practice of Palliative Care and Supportive Oncology. Philadelphia, Pa: Lippincott Raven Publishers; 1998.